Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="SENAN, S" or (type exact bookEditor and editor="SENAN, S")

Add to list
- Journal Article
- A1
- open access
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic : an ESTRO-ASTRO consensus statement q

M Guckenberger, C Belka, A Bezjak, J Bradley, ME Daly, D DeRuysscher, R Dziadziuszko, C Faivre-Finn, M Flentje, E Gore, et al.

(2020) RADIOTHERAPY AND ONCOLOGY. 146. p.223-229
Add to list
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

C Le Péchoux, A Laplanche, C Faivre-Finn, T Ciuleanu, R. Wanders, D Lerouge, R Keus, M Hatton, GM Videtic, S Senan, et al.

(2011) ANNALS OF ONCOLOGY. 22(5). p.1154-1163
Add to list
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies

Veerle Surmont (UGent) , EF Smit, M de Jonge, JG Aerts, K Nackaerts, R Vernhout, J Gras, A Van Wijk, ECJ Phernambucq, JP van Meerbeeck, et al.

(2010) LUNG CANCER. 69(3). p.302-306
Add to list
- Journal Article
- A1
Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer

Jan Van Meerbeeck (UGent) , PEY VAN SCHIL and S SENAN

(2007) JOURNAL OF THORACIC ONCOLOGY. 2(12). p.1138-1139
Add to list
- Journal Article
- A1
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

P BAAS, JSA BELDERBOS, S SENAN, HB KWA, A VAN BOCHOVE, H VAN TINTEREN, JA BURGERS and Jan Van Meerbeeck (UGent)

(2006) BRITISH JOURNAL OF CANCER. 94(5). p.625-630
Add to list
- Conference Paper
- C3
Treatment compliance and early toxicity of 3D involved-field radiotherapy (RT) and chemotherapy (CT) in a randomized study comparing induction CT followed by concurrent CT-RT with concurrent CT-RT followed by consolidation CT, in non-small-cell lung cancer (NSCLC)

S SENAN, Jan Van Meerbeeck (UGent) , F CARDENAL, J VAN STEENKISTE, J STIGT, F AKYOL, J BAKKER, J DUPONT, W DE GERSEM and U RICARDI

(2006) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 66(3).
Add to list
- Journal Article
- A1
A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer

JGJV AERTS, V SURMONT, RJ VAN KLAVEREN, KY TAN, S SENAN, G VAN WIJHE, R VERNHOUT, GT VERHOEVEN, HC HOOGSTEDEN and Jan Van Meerbeeck (UGent)

(2006) JOURNAL OF THORACIC ONCOLOGY. 1(6). p.532-536

Academic Bibliography

Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic : an ESTRO-ASTRO consensus statement q

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies

Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

Treatment compliance and early toxicity of 3D involved-field radiotherapy (RT) and chemotherapy (CT) in a randomized study comparing induction CT followed by concurrent CT-RT with concurrent CT-RT followed by consolidation CT, in non-small-cell lung cancer (NSCLC)

A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer

Contents

Support

Contact